Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC4C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | NSG1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
mRNA | ZNF45 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | APEH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZNF382 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | VPS72 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SLC25A36 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DRICH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CCDC51 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |